News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
News|Slideshows|July 31, 2025

July Pharmaceutical Industry Movers & Shakers

Author(s)Don Tracy, Associate Editor

A monthly roundup of business and people news in the pharmaceutical industry.

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Alistair Henry

The Risk Reward Equation in Research & Development Leadership

ByAlistair Henry
April 1st 2026

What Potential Fallout Will MFN Policies Have?

ByMike Hollan,Lindsay Bealor Greenleaf
April 1st 2026
Pharmaceutical Executive podcast

Pharmaceutical Executive Daily: Novo Nordisk's Wegovy Subscription Program

ByNicholas Jacobus
March 31st 2026
Stock.adobe.com GLP-1

Novo Nordisk Launches Multi-Month Subscription Program for Wegovy

ByNicholas Jacobus
March 31st 2026
Stock.adobe.com

Merck Enters $838 Million Research & Development Collaboration with Infinimmune

ByNicholas Jacobus
March 31st 2026
Advertisement
Advertisement

Trending on PharmExec

1

Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments

2

Novo Nordisk Launches Multi-Month Subscription Program for Wegovy

3

Merck Enters $838 Million Research & Development Collaboration with Infinimmune

4

How Will MFN’s Effects on Medicare Impact Innovation?

5

Pharmaceutical Executive Daily: Novo Nordisk's Wegovy Subscription Program

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us